Jim Simons Equillium, Inc. Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Equillium, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 269,500 shares of EQ stock, worth $102,410. This represents 0.0% of its overall portfolio holdings.

Number of Shares

269,500

Previous 261,400 3.1%

Holding current value

$102,410

Previous $206,000 49.03%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$0.39 - $0.94 $3,159 - $7,614	8,100 Added 3.1%	269,500 $105,000
Q4 2024 Feb 13, 2025	SELL	$0.6 - $1.38 $35,863 - $82,486	-59,773 Reduced 18.61%	261,400 $206,000
Q3 2024 Nov 13, 2024	BUY	$0.64 - $1.13 $13,294 - $23,473	20,773 Added 6.92%	321,173 $266,000
Q2 2024 Aug 09, 2024	BUY	$0.66 - $2.33 $60,192 - $212,496	91,200 Added 43.59%	300,400 $207,000
Q1 2024 May 13, 2024	SELL	$0.73 - $3.0 $100,959 - $414,900	-138,300 Reduced 39.8%	209,200 $483,000
Q4 2023 Feb 13, 2024	BUY	$0.48 - $0.74 $26,020 - $40,114	54,209 Added 18.48%	347,500 $251,000
Q3 2023 Nov 14, 2023	SELL	$0.72 - $0.9 $71,236 - $89,046	-98,940 Reduced 25.22%	293,291 $217,000
Q2 2023 Aug 11, 2023	BUY	$0.49 - $0.79 $173,230 - $279,289	353,531 Added 913.52%	392,231 $294,000
Q1 2023 May 12, 2023	BUY	$0.56 - $1.24 $9,072 - $20,088	16,200 Added 72.0%	38,700 $28,000
Q4 2022 Feb 13, 2023	BUY	$0.83 - $2.26 $4,399 - $11,977	5,300 Added 30.81%	22,500 $24,000
Q3 2022 Nov 14, 2022	BUY	$1.93 - $3.14 $1,351 - $2,198	700 Added 4.24%	17,200 $38,000
Q2 2022 Aug 12, 2022	BUY	$1.69 - $3.26 $27,885 - $53,790	16,500 New	16,500 $34,000
Q1 2021 May 13, 2021	SELL	$5.03 - $10.5 $208,790 - $435,844	-41,509 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$3.48 - $6.58 $229,123 - $433,227	-65,840 Reduced 61.33%	41,509 $222,000
Q3 2020 Nov 13, 2020	BUY	$2.78 - $26.5 $20,016 - $190,800	7,200 Added 7.19%	107,349 $619,000
Q2 2020 Aug 13, 2020	BUY	$2.34 - $3.53 $92,902 - $140,148	39,702 Added 65.68%	100,149 $295,000
Q1 2020 May 14, 2020	BUY	$2.3 - $5.5 $81,436 - $194,738	35,407 Added 141.4%	60,447 $164,000
Q4 2019 Feb 13, 2020	BUY	$3.0 - $5.0 $75,120 - $125,200	25,040 New	25,040 $85,000

Others Institutions Holding EQ

# of Institutions

Shares Held

11.3M

Call Options Held

13.2K

Put Options Held

100

View Full List

About Equillium, Inc.

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $13.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

More about EQ

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account